Plain-English translation of NCT07915024 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called HSK31858 in healthy volunteers. Researchers want to understand how the medication affects the heart's electrical system, specifically a measurement called the QT interval. The study will give participants either a single dose or multiple doses of the medication, and carefully monitor their heart health.
Before this medication can be tested in patients with lung disease, researchers need to make sure it doesn't cause harmful effects on the heart. This safety study helps them understand the medication's effects in healthy people first.
You likely qualify if…
You likely don't qualify if…
You will come to the study center where you'll receive either a single dose or multiple doses of the medication over a set period. Researchers will monitor your heart with repeated ECG tests, take blood samples, and check your vital signs regularly. The study involves several clinic visits where medical staff will track how your body responds to the medication to ensure it's safe.
AI-generated summary from trial data · Nov 9, 2026 · Not medical advice
China